tm
Seeing Is Believing
tm
Seeing Is Believing
SRPT is currently covered by 23 analysts with an average potential upside of $34.38 (39.7%) from yesterday's end of day stock price of $88.14. Sarepta Therapeutics activity chart has currently 414 price targets and 507 ratings on display.
Analysts average stock forecasts to be materialized ratio is 56.6% with an average time for these price targets to be met of 220.97 days.
Highest price target for SRPT is $157, Lowest price target is $66, average price target is $111.5.
Most recent stock forecast was given by BRIAN ABRAHAMS from RBC on 21-Nov-2023. First documented stock forecast 20-Mar-2013.
Currently, out of the existing stock ratings of SRPT - 76 which are a Buy (75.25%), 25 which are a Hold (24.75%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
148
$59.86 (67.91%)
148
15 days ago
9/35 (25.71%)
$67.73 (61.67%)
354
Buy
141
$52.86 (59.97%)
193
1 months 4 days ago
5/12 (41.67%)
$15.55 (11.29%)
19
Hold
80
$-8.14 (-9.24%)
40
1 months 4 days ago
2/8 (25%)
$31.55 (27.10%)
92
Buy
93
$4.86 (5.51%)
82
1 months 4 days ago
5/15 (33.33%)
$53.74 (55.66%)
296
Buy
146
$57.86 (65.65%)
183
1 months 5 days ago
14/23 (60.87%)
$22.53 (21.31%)
317
What is SRPT (Sarepta Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on SRPT (Sarepta Therapeutics) with a proven track record?
Which analyst has the most public recommendations on SRPT (Sarepta Therapeutics)?
Which analyst is the currently most bullish on SRPT (Sarepta Therapeutics)?
Which analyst is the currently most reserved on SRPT (Sarepta Therapeutics)?
